This inventor holds 1 USPTO granted patent. Top assignee: Agouron Pharmaceuticals, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Bing Shi in Pharmaceutical Chemistry
Introduction: Bing Shi is a notable inventor based in San Diego, California, who has made significant contributions to the field of pharmaceutical chemistry. His work primarily focuses on the development of methods related to indazole compounds, which play a crucial role as modulators and inhibitors of protein kinases.
Latest Patents: Bing Shi holds one patent titled "Methods of Preparing Indazole Compounds." This patent details innovative methods for synthesizing indazole compounds, which are essential for advancing therapeutic strategies in treating various diseases. The patent emphasizes the importance of intermediate compounds that facilitate the preparation of these advanced compounds, crucial for drug development.
Career Highlights: Currently, Bing Shi is affiliated with Agouron Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His research efforts contribute to the company's mission of developing impactful therapies and improving patient care through advanced medicinal chemistry.
Collaborations: Throughout his career, Bing has collaborated with talented professionals, including Brigitte Leigh Ewanicki and Erik Jon Flahive. These partnerships enhance his ability to innovate and refine his research methodologies, leading to successful outcomes in his projects.
Conclusion: Bing Shi's work exemplifies the spirit of innovation in the pharmaceutical industry. His patented methods for preparing indazole compounds not only highlight his expertise but also showcase the collaborative efforts that drive significant advancements in drug development. As researchers like Bing continue to explore new frontiers, the potential for transformative therapies increases, benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile